Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
企業コードTEM
会社名Tempus AI Inc
上場日May 30, 2025
最高経営責任者「CEO」Lefkofsky (Eric P)
従業員数2400
証券種類Ordinary Share
決算期末May 30
本社所在地600 West Chicago Avenue
都市CHICAGO
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号60654
電話番号18335144187
ウェブサイトhttps://investors.tempus.com/
企業コードTEM
上場日May 30, 2025
最高経営責任者「CEO」Lefkofsky (Eric P)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし